Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Jessie M. English"'
Autor:
Matthew V. Lorenzi, Raluca I. Verona, Kwok-Kin Wong, Christopher Moy, Pasi A. Janne, Kathryn Packman, Paul T. Kirschmeier, Mark A. Bittinger, Sylvie Laquerre, Catherine Sanders, Julie A. Rytlewski, Andrew H. Beck, Aditya Khosla, Jessie M. English, Catherine Ferrante, Elena Ivanova, Samuel N. Regan, Dyane Bailey, Martha R. Gowaski, Kristin DePeaux, Abha Dhaneshwar, Jeffrey Liu, Dennis M. Bonal, Wei Huang, Enrique Zudaire, Sima J. Zacharek, Mari Kuraguchi, Sangeetha Palakurthi
Supplemental figure legends 1-8, Supplementary tables 1-5, and Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::081db4e460edcdbbb5c8116b2f80a570
https://doi.org/10.1158/2326-6066.22543410
https://doi.org/10.1158/2326-6066.22543410
Autor:
Matthew V. Lorenzi, Raluca I. Verona, Kwok-Kin Wong, Christopher Moy, Pasi A. Janne, Kathryn Packman, Paul T. Kirschmeier, Mark A. Bittinger, Sylvie Laquerre, Catherine Sanders, Julie A. Rytlewski, Andrew H. Beck, Aditya Khosla, Jessie M. English, Catherine Ferrante, Elena Ivanova, Samuel N. Regan, Dyane Bailey, Martha R. Gowaski, Kristin DePeaux, Abha Dhaneshwar, Jeffrey Liu, Dennis M. Bonal, Wei Huang, Enrique Zudaire, Sima J. Zacharek, Mari Kuraguchi, Sangeetha Palakurthi
The success of targeted or immune therapies is often hampered by the emergence of resistance and/or clinical benefit in only a subset of patients. We hypothesized that combining targeted therapy with immune modulation would show enhanced antitumor re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ef82160a04751b2f6d5b28b394c18e
https://doi.org/10.1158/2326-6066.c.6550248
https://doi.org/10.1158/2326-6066.c.6550248
Autor:
Matthew V. Lorenzi, Raluca I. Verona, Kwok-Kin Wong, Christopher Moy, Pasi A. Janne, Kathryn Packman, Paul T. Kirschmeier, Mark A. Bittinger, Sylvie Laquerre, Catherine Sanders, Julie A. Rytlewski, Andrew H. Beck, Aditya Khosla, Jessie M. English, Catherine Ferrante, Elena Ivanova, Samuel N. Regan, Dyane Bailey, Martha R. Gowaski, Kristin DePeaux, Abha Dhaneshwar, Jeffrey Liu, Dennis M. Bonal, Wei Huang, Enrique Zudaire, Sima J. Zacharek, Mari Kuraguchi, Sangeetha Palakurthi
Supplemental Figures 1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a9d829db39fa7ca6cf8c4ce7a4a356
https://doi.org/10.1158/2326-6066.22543413
https://doi.org/10.1158/2326-6066.22543413
Autor:
Raphael Bueno, Kwok-Kin Wong, Peter S. Hammerman, Lynette M. Sholl, Pasi A. Jänne, Kai W. Wucherpfennig, F. Stephen Hodi, Scott J. Rodig, Adam J. Bass, David A. Barbie, William G. Richards, Julianne Barlow, Jessie M. English, Christina Almonte, Shohei Koyama, Lauren Keogh, Mark A. Bittinger, Abigail A. Santos, Xiaoyun Liao, Grit S. Herter-Sprie, Meghana Kulkarni, Elena V. Ivanova, Patrick H. Lizotte, Hongye Liu, Robert E. Jones, Mark M. Awad
PD-L1 immunohistochemical staining does not always predict whether a cancer will respond to treatment with PD-1 inhibitors. We sought to characterize immune cell infiltrates and the expression of T-cell inhibitor markers in PD-L1–positive and PD-L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969115837501efc52aa2af781bec38a1
https://doi.org/10.1158/2326-6066.c.6548897.v1
https://doi.org/10.1158/2326-6066.c.6548897.v1
Autor:
Raphael Bueno, Kwok-Kin Wong, Peter S. Hammerman, Lynette M. Sholl, Pasi A. Jänne, Kai W. Wucherpfennig, F. Stephen Hodi, Scott J. Rodig, Adam J. Bass, David A. Barbie, William G. Richards, Julianne Barlow, Jessie M. English, Christina Almonte, Shohei Koyama, Lauren Keogh, Mark A. Bittinger, Abigail A. Santos, Xiaoyun Liao, Grit S. Herter-Sprie, Meghana Kulkarni, Elena V. Ivanova, Patrick H. Lizotte, Hongye Liu, Robert E. Jones, Mark M. Awad
Supplemental Figure 1. Difference in CD3+ immune cell infiltrates by histologic subtype of mesothelioma. Supplemental Figure 2. Comparison of immune cell infiltrates among patients who received or did not receive neoadjuvant chemotherapy prior to sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12fcd7701894d021c3a6f8e05cee05c3
https://doi.org/10.1158/2326-6066.22538795.v1
https://doi.org/10.1158/2326-6066.22538795.v1
Autor:
Yan Lan, Laszlo Radvanyi, Jessie M. English, Kin-Ming Lo, Robert Tighe, Huakui Yu, Hong Wang, Jin Qi, Guozhong Qin, Bo Marelli, Giorgio Kradjian, Wilson Guzman, Vivian M. Hernández, P. Alexander Rolfe, Yanping Zhang, Chunxiao Xu
NHS-muIL12 and avelumab combination treatment enhanced the necrotic fraction in EMT-6 tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b5e2418003998f6f97dbd83cc9de8c7
https://doi.org/10.1158/1078-0432.22465718
https://doi.org/10.1158/1078-0432.22465718
Autor:
Geoffrey R. Oxnard, Pasi A. Jänne, Lee P. Lim, Jessie M. English, Paul Kirschmeier, Leena Gandhi, Yanan Kuang, Stacy L. Mach, Allison O'Connell, Ryan S. Alden, Chris K. Raymond, Adrian G. Sacher, Cloud P. Paweletz
Supplemental Table 3: Summary of ddPCR and NGS findings. The table shows the tissue genotype, ddPCR results, ddPCR allele frequency (mut / mut +wt allele frequency), NGS mutation calls and allele frequencies, and sequencing reads.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c9b818f3ff98931a9b9e55f608c899e
https://doi.org/10.1158/1078-0432.22461074.v1
https://doi.org/10.1158/1078-0432.22461074.v1
Autor:
Geoffrey R. Oxnard, Pasi A. Jänne, Lee P. Lim, Jessie M. English, Paul Kirschmeier, Leena Gandhi, Yanan Kuang, Stacy L. Mach, Allison O'Connell, Ryan S. Alden, Chris K. Raymond, Adrian G. Sacher, Cloud P. Paweletz
Supplemental Table 1: Summary of probe sequences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9804c74831d64786a614e30df6a1cfe
https://doi.org/10.1158/1078-0432.22461080
https://doi.org/10.1158/1078-0432.22461080
Autor:
Yan Lan, Laszlo Radvanyi, Jessie M. English, Kin-Ming Lo, Robert Tighe, Huakui Yu, Hong Wang, Jin Qi, Guozhong Qin, Bo Marelli, Giorgio Kradjian, Wilson Guzman, Vivian M. Hernández, P. Alexander Rolfe, Yanping Zhang, Chunxiao Xu
Purpose: To determine whether combination therapy with NHS-muIL12 and the anti-programmed death ligand 1 (PD-L1) antibody avelumab can enhance antitumor efficacy in preclinical models relative to monotherapies.Experimental Design: BALB/c mice bearing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7409a00569a1a7bee4c843188c7686
https://doi.org/10.1158/1078-0432.c.6526130.v1
https://doi.org/10.1158/1078-0432.c.6526130.v1
Autor:
Yan Lan, Laszlo Radvanyi, Jessie M. English, Kin-Ming Lo, Robert Tighe, Huakui Yu, Hong Wang, Jin Qi, Guozhong Qin, Bo Marelli, Giorgio Kradjian, Wilson Guzman, Vivian M. Hernández, P. Alexander Rolfe, Yanping Zhang, Chunxiao Xu
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::666d52327eae76947265f5115a307fbd
https://doi.org/10.1158/1078-0432.22465709.v1
https://doi.org/10.1158/1078-0432.22465709.v1